Sublingual immunotherapy provides an early increase of interferon-gamma production

Giorgio Ciprandi; D. Fenoglio; M. Di Gioacchino; A. Ferrera; F. Ferrera; M. P. Sormani; G. L. Marseglia

Sublingual immunotherapy provides an early increase of interferon-gamma production

Giorgio Ciprandi, D. Fenoglio, M. Di Gioacchino, A. Ferrera, F. Ferrera, M. P. Sormani, G. L. Marseglia

Research output: Contribution to journal › Article › peer-review

Abstract

Allergic rhinitis (AR) is characterized by Th2 polarized immune response. Allergen-specific subcutaneous immunotherapy: may restore a physiologic Th1 profile. However, there are few studies investigating the immunological effects of sublingual immunotherapy (SLIT). The aim of this study is to investigate whether a pre-seasonal SLIT course could affect IFN-γ production. Forty-four AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. IFN-γ-specific producing cells were assessed by cytokine ELISPOT before and 3 months after the beginning of SLIT. Visual analogue scale (VAS) for symptoms and medication score was also evaluated. The frequency of IFN-γ-specific producing cells significantly increased after SLIT (p

Original language	English
Pages (from-to)	169-173
Number of pages	5
Journal	Journal of Biological Regulators and Homeostatic Agents
Volume	22
Issue number	3
Publication status	Published - Jul 2008

Keywords

Early marker of response
ELISPOT
IFN-γ production
Sublingual immunotherapy
Th1 cells

ASJC Scopus subject areas

Oncology
Endocrinology, Diabetes and Metabolism
Physiology (medical)
Immunology and Allergy
Immunology
Endocrinology
Physiology
Cancer Research

Cite this

@article{1dcbb62e0145470382611eaec71ddcfa,

title = "Sublingual immunotherapy provides an early increase of interferon-gamma production",

abstract = "Allergic rhinitis (AR) is characterized by Th2 polarized immune response. Allergen-specific subcutaneous immunotherapy: may restore a physiologic Th1 profile. However, there are few studies investigating the immunological effects of sublingual immunotherapy (SLIT). The aim of this study is to investigate whether a pre-seasonal SLIT course could affect IFN-γ production. Forty-four AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. IFN-γ-specific producing cells were assessed by cytokine ELISPOT before and 3 months after the beginning of SLIT. Visual analogue scale (VAS) for symptoms and medication score was also evaluated. The frequency of IFN-γ-specific producing cells significantly increased after SLIT (p",

keywords = "Early marker of response, ELISPOT, IFN-γ production, Sublingual immunotherapy, Th1 cells",

author = "Giorgio Ciprandi and D. Fenoglio and {Di Gioacchino}, M. and A. Ferrera and F. Ferrera and Sormani, {M. P.} and Marseglia, {G. L.}",

year = "2008",

month = jul,

language = "English",

volume = "22",

pages = "169--173",

journal = "Journal of Biological Regulators and Homeostatic Agents",

issn = "0393-974X",

publisher = "Biolife s.a.s.",

number = "3",

}

TY - JOUR

T1 - Sublingual immunotherapy provides an early increase of interferon-gamma production

AU - Ciprandi, Giorgio

AU - Fenoglio, D.

AU - Di Gioacchino, M.

AU - Ferrera, A.

AU - Ferrera, F.

AU - Sormani, M. P.

AU - Marseglia, G. L.

PY - 2008/7

Y1 - 2008/7

N2 - Allergic rhinitis (AR) is characterized by Th2 polarized immune response. Allergen-specific subcutaneous immunotherapy: may restore a physiologic Th1 profile. However, there are few studies investigating the immunological effects of sublingual immunotherapy (SLIT). The aim of this study is to investigate whether a pre-seasonal SLIT course could affect IFN-γ production. Forty-four AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. IFN-γ-specific producing cells were assessed by cytokine ELISPOT before and 3 months after the beginning of SLIT. Visual analogue scale (VAS) for symptoms and medication score was also evaluated. The frequency of IFN-γ-specific producing cells significantly increased after SLIT (p

AB - Allergic rhinitis (AR) is characterized by Th2 polarized immune response. Allergen-specific subcutaneous immunotherapy: may restore a physiologic Th1 profile. However, there are few studies investigating the immunological effects of sublingual immunotherapy (SLIT). The aim of this study is to investigate whether a pre-seasonal SLIT course could affect IFN-γ production. Forty-four AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. IFN-γ-specific producing cells were assessed by cytokine ELISPOT before and 3 months after the beginning of SLIT. Visual analogue scale (VAS) for symptoms and medication score was also evaluated. The frequency of IFN-γ-specific producing cells significantly increased after SLIT (p

KW - Early marker of response

KW - ELISPOT

KW - IFN-γ production

KW - Sublingual immunotherapy

KW - Th1 cells

UR - http://www.scopus.com/inward/record.url?scp=58949093503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949093503&partnerID=8YFLogxK

M3 - Article

C2 - 18842170

AN - SCOPUS:58949093503

VL - 22

SP - 169

EP - 173

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 3

ER -

Sublingual immunotherapy provides an early increase of interferon-gamma production

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this